Inovio Pharmaceuticals, Inc.
INO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001055726
No open-market purchases or sales by Inovio Pharmaceuticals, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $36.1M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Inovio Pharmaceuticals, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 89 | 1 | 96 | +8 |
| Shares | 4.07M | 4 | 8.06M | +3.99M (+98.1%) |
| Value | $56.4M | $56 | $65.1M | +$8.72M (+15.5%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (30)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (22)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Gsa Capital Partners LLP | 79,979 | $1.11M |
| HRT Financial LP | 76,695 | $1.06M |
| Marshall Wace, LLP | 51,983 | $721.5K |
| Marathon Trading Investment Management LLC | 30,300 | $420.6K |
| HighTower Advisors, LLC | 29,918 | $413.0K |
| GTS Securities LLC | 23,479 | $325.9K |
| Balyasny Asset Management LLC | 22,246 | $308.8K |
| Squarepoint Ops LLC | 21,721 | $301.5K |
| Brevan Howard Capital Management LP | 21,237 | $294.8K |
| ExodusPoint Capital Management, LP | 17,690 | $246.0K |
| Y-Intercept (Hong Kong) Ltd | 15,245 | $211.6K |
| Susquehanna International Group, LLP | 14,694 | $204.0K |
| Jefferies Financial Group Inc. | 11,500 | $159.6K |
| Cedar Brook Financial Partners, LLC | 10,876 | $151.0K |
| Amundi | 11,606 | $118.4K |
| Catalyst Funds Management Pty Ltd | 8,411 | $116.7K |
| Headlands Technologies LLC | 1,360 | $18.9K |
| Householder Group Estate & Retirement Specialist, LLC | 106 | $1.47K |
| Northwestern Mutual Wealth Management Co | 30 | $416 |
| Sofos Investments, Inc. | 15 | $212 |
| Johnson Financial Group, Inc. | 1 | $14 |
| Sachetta, LLC | 3 | $2 |
Not filed for Q2 2024 yet (1)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Highlander Capital Management, LLC | 4 | $56 |